Top Markets
Coin of the day
Emcure Pharmaceuticals Ltd. Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd.

EMCURE
株式のランク #4304
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
株価
$20.55
時価総額
$3.90B
変化(1日)
0.83%
変化(1年)
22.65%
IN
取引 Emcure Pharmaceuticals Ltd. (EMCURE)

カテゴリー

Emcure Pharmaceuticals Ltd.(EMCURE)の配当利回りの履歴
Emcure Pharmaceuticals Ltd.(銘柄コード: EMCURE)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Emcure Pharmaceuticals Ltd.(EMCURE)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)